1205 Factors Associated With Hormonal Dysfunction Following Pituitary Tumor Apoplexy and Prolactin as an Early Biomarker for Post-apoplexy Endocrinopathy: A Single Center Analytical Study

View at publisher Summarise with VIRAT
Authors: Soumya Pahari, Eduardo J. Medina, Jesse D. Lawrence, Adnan Haider, Tariq Latif, Jeremy J. Lewis
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Pituitary apoplexy due to infarction or hemorrhage can result in visual deficits and pituitary endocrine dysfunction. Studies indicate that hormonal dysfunction persists in over half of affected patients regardless of management strategy. However, no clinical tool currently exists to predict endocrine recovery. METHODS: A retrospective review was conducted of patients with pituitary apoplexy from 2013 to 2022. Data on demographics, serum prolactin levels at presentation, treatment modality, surgical details, and endocrine outcomes at last follow-up were analyzed. Univariate analysis was performed to assess associations with hormonal dysfunction. A receiver operating characteristic (ROC) curve evaluated the diagnostic value of prolactin. RESULTS: Twenty-three patients were identified (mean age 66.83 ± 13.94 years; 15 males). Twenty patients (86.96%) underwent surgical treatment. Hormonal dysfunction affecting at least one pituitary axis was present in 78.26% (18/23) at follow-up. Male sex (OR = 12.11, 95% CI: 0.89–732.73, p = 0.039) and hormonal dysfunction at presentation (OR = 20.04, 95% CI: 1.27–1356.87, p = 0.0139) were significantly associated with persistent endocrinopathy. Patients with dysfunction had significantly lower prolactin levels at presentation (3.1 vs 17.8 ng/ml, p = 0.019). Low prolactin levels predicted hormonal dysfunction on univariate logistic regression (OR = 0.89, 95% CI: 0.79–1.00, p = 0.047). ROC analysis identified a prolactin threshold of

Fields of Study & Subjects

Pituitary Gland Disorders and Treatments Electrolyte and hormonal disorders Neuroendocrine Tumor Research Advances

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
236–236
Publication date
26 March 2026
Language
EN